Journal of Pharmaceutical Investigation
- 제31권2호
- /
- Pages.89-94
- /
- 2001
- /
- 2093-5552(pISSN)
- /
- 2093-6214(eISSN)
인과립구 콜로니 자극인자 제제인 HM10411와 필그라스팀의 정맥, 근육 및 피하 주사시 흰쥐와 마우스에서의 약물 동태
Pharmacokinetics of Recombinant Human Granulocyte Colony Stimulating Factor (rhG-CSF) Following Intravenous, Intramuscular and Subcutaneous Administration of HM10411 and Filgrastim to Rats and Mice
- 김인화 (서울대학교 약학대학 종합약학 연구소) ;
- 이상훈 (한미약품공업주식회사) ;
- 김영민 (한미약품공업주식회사) ;
- 정성엽 (한미약품공업주식회사) ;
- 권세창 (한미약품공업주식회사) ;
- 이관순 (한미약품공업주식회사) ;
- 정석재 (서울대학교 약학대학 종합약학 연구소) ;
- 심창구 (서울대학교 약학대학 종합약학 연구소)
- Kim, In-Wha (Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University) ;
- Lee, Sang-Hoon (Central Research Institute, Hanmi Pharm. Co. Ltd.) ;
- Kim, Young-Min (Central Research Institute, Hanmi Pharm. Co. Ltd.) ;
- Jung, Sung-Youb (Central Research Institute, Hanmi Pharm. Co. Ltd.) ;
- Kwon, Se-Chang (Central Research Institute, Hanmi Pharm. Co. Ltd.) ;
- Lee, Gwan-Sun (Central Research Institute, Hanmi Pharm. Co. Ltd.) ;
- Chung, Suk-Jae (Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University) ;
- Shim, Chang-Koo (Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University)
- 발행 : 2001.06.20
초록
The pharmacokinetics of recombinant human granulocyte colony stimulating factor (rhG-CSF) following intravenous (i.v.), intramuscular (i.m.) and subcutaneous (s.c.) administration of HM1041l-lyo and HM10411-liq (lyophilized and liquid formulations of rhG-CSF, recently under development by Hanmi Pharmaceutical Company) were studied in rats, and compared with that of Filgrastim (conventional formulation of rhG-CSF on market). The plasma concentration of rhG-CSF was quantified using a specific ELISA. The pharmacokinetic parameters of rhG-CSF, after i.v., i.m. and s.c. administration of Filgrastim, HM1041l-lyo and HM1041l-liq to rats at a rhG-CSF dose of
키워드